Leptomeningeal metastases from solid tumors are a rare complication with a very poor prognosis. Here the authors report the efficacy and safety of combined ipilimumab and nivolumab in patients with leptomeningeal carcinomatosis.
Xehetasun bibliografikoak
| Egile Nagusiak: |
Priscilla K. Brastianos,
Matthew R. Strickland,
Eudocia Quant Lee,
Nancy Wang,
Justine V. Cohen,
Ugonma Chukwueke,
Deborah Anne Forst,
April Eichler,
Beth Overmoyer,
Nancy U. Lin,
Wendy Y. Chen,
Aditya Bardia,
Dejan Juric,
Ibiayi Dagogo-Jack,
Michael D. White,
Jorg Dietrich,
Naema Nayyar,
Albert E. Kim,
Christopher Alvarez-Breckenridge,
Maura Mahar,
Joana L. Mora,
Brian V. Nahed,
Pamela S. Jones,
Helen A. Shih,
Elizabeth R. Gerstner,
Anita Giobbie-Hurder,
Scott L. Carter,
Kevin Oh,
Daniel P. Cahill,
Ryan J. Sullivan |
|---|
| Formatua: | Artikulua
|
|---|
| Hizkuntza: | English |
|---|
| Argitaratua: |
Nature Portfolio
2021-10-01
|
|---|
| Saila: | Nature Communications
|
|---|
| Sarrera elektronikoa: | https://doi.org/10.1038/s41467-021-25859-y
|
|---|